NEUPATH HEALTH REPORTS SECOND QUARTER 2024 RESULTS

• Delivered record second quarter total revenue of $18.9 million, up 11% year-over-year
• Adjusted EBITDA⁽¹⁾ of $1.3 million, our 22^nd consecutive quarter of positive adjusted EBITDA
• Improved cash flows, with net debt down 37% versus June 30, 2023

TORONTO, ONTARIO, August 15, 2024 – NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three and six months ended June 30, 2024. All figures are in Canadian dollars, unless otherwise noted.

“The focus on our core clinics business over the past two years is delivering improved financial results, a reduced debt burden, and improved facilities,” said Joe Walewicz, NeuPath’s Chief Executive Officer. “In the next few quarters, we will continue to invest in our facilities to better serve our patients in the community.”

Financial and Operational Highlights

• Record total revenue of $18.9 million and $36.4 million for the three and six months ended June 30, 2024, up 11% and 10% year-over-year, respectively;
• Adjusted EBITDA was $1.3 million and $2.2 million for the three and six months ended June 30, 2024, up 30% and 22% year-over-year, respectively;
• For the six months ended June 30, 2024, capacity utilization improved to 75%, up from 68% for the six months ended June 30, 2023; and
• As at June 30, 2024, the Company had $2.9 million in cash and cash equivalents and long-term debt of $6.0 million, of which $2.3 million is interest-bearing.

⁽¹⁾Non-International Financial Reporting Standard (“IFRS”) and Other Financial Measures defined by the Company below.

See more  Press Release PDF